BioMarin Pharmaceutical Inc. (BMRN)
Total Valuation
BMRN has a market cap or net worth of $16.72 billion. The enterprise value is $16.73 billion.
Market Cap | 16.72B |
Enterprise Value | 16.73B |
Important Dates
The next estimated earnings date is Wednesday, April 24, 2024, after market close.
Earnings Date | Apr 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BMRN has 188.68 million shares outstanding. The number of shares has increased by 1.39% in one year.
Shares Outstanding | 188.68M |
Shares Change (YoY) | +1.39% |
Shares Change (QoQ) | -5.19% |
Owned by Insiders (%) | 0.68% |
Owned by Institutions (%) | 101.51% |
Float | 187.26M |
Valuation Ratios
The trailing PE ratio is 101.38 and the forward PE ratio is 52.93. BMRN's PEG ratio is 0.73.
PE Ratio | 101.38 |
Forward PE | 52.93 |
PS Ratio | 6.91 |
Forward PS | 5.96 |
PB Ratio | 3.38 |
P/FCF Ratio | 267.21 |
PEG Ratio | 0.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 53.92, with an EV/FCF ratio of 267.42.
EV / Earnings | 99.80 |
EV / Sales | 6.92 |
EV / EBITDA | 53.92 |
EV / EBIT | 81.26 |
EV / FCF | 267.42 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.22.
Current Ratio | 2.51 |
Quick Ratio | 1.45 |
Debt / Equity | 0.22 |
Debt / EBITDA | 3.50 |
Debt / FCF | 17.37 |
Interest Coverage | 11.88 |
Financial Efficiency
Return on equity (ROE) is 3.50% and return on invested capital (ROIC) is 2.33%.
Return on Equity (ROE) | 3.50% |
Return on Assets (ROA) | 2.50% |
Return on Capital (ROIC) | 2.33% |
Revenue Per Employee | $711,328 |
Profits Per Employee | $49,293 |
Employee Count | 3,401 |
Asset Turnover | 0.36 |
Inventory Turnover | 0.51 |
Taxes
In the past 12 months, BMRN has paid $20.92 million in taxes.
Income Tax | 20.92M |
Effective Tax Rate | 11.09% |
Stock Price Statistics
The stock price has decreased by -3.16% in the last 52 weeks. The beta is 0.31, so BMRN's price volatility has been lower than the market average.
Beta (1Y) | 0.31 |
52-Week Price Change | -3.16% |
50-Day Moving Average | 88.22 |
200-Day Moving Average | 89.30 |
Relative Strength Index (RSI) | 58.19 |
Average Volume (30 Days) | 1,325,206 |
Short Selling Information
The latest short interest is 2.96 million, so 1.57% of the outstanding shares have been sold short.
Short Interest | 2.96M |
Short Previous Month | 3.06M |
Short % of Shares Out | 1.57% |
Short % of Float | 1.58% |
Short Ratio (days to cover) | 1.94 |
Income Statement
In the last 12 months, BMRN had revenue of $2.42 billion and earned $167.65 million in profits. Earnings per share was $0.87.
Revenue | 2.42B |
Gross Profit | 1.90B |
Operating Income | 158.10M |
Pretax Income | 188.56M |
Net Income | 167.65M |
EBITDA | 310.28M |
EBIT | 205.90M |
Earnings Per Share (EPS) | $0.87 |
Balance Sheet
The company has $1.07 billion in cash and $1.09 billion in debt, giving a net cash position of -$13.16 million or -$0.07 per share.
Cash & Cash Equivalents | 1.07B |
Total Debt | 1.09B |
Net Cash | -13.16M |
Net Cash Per Share | -$0.07 |
Equity / Book Value | 4.95B |
Book Value Per Share | 26.24 |
Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was $159.26 million and capital expenditures -$96.69 million, giving a free cash flow of $62.57 million.
Operating Cash Flow | 159.26M |
Capital Expenditures | -96.69M |
Free Cash Flow | 62.57M |
FCF Per Share | $0.33 |
Margins
Gross margin is 78.72%, with operating and profit margins of 6.54% and 6.93%.
Gross Margin | 78.72% |
Operating Margin | 6.54% |
Pretax Margin | 7.79% |
Profit Margin | 6.93% |
EBITDA Margin | 12.83% |
EBIT Margin | 8.51% |
FCF Margin | 2.59% |
Dividends & Yields
BMRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.39% |
Shareholder Yield | -1.39% |
Earnings Yield | 1.00% |
FCF Yield | 0.37% |
Analyst Forecast
The average price target for BMRN is $108.28, which is 23.89% higher than the current price. The consensus rating is "Buy".
Price Target | $108.28 |
Price Target Difference | 23.89% |
Analyst Consensus | Buy |
Analyst Count | 19 |
Revenue Growth Forecast (5Y) | 13.90% |
EPS Growth Forecast (5Y) | 52.19% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BMRN has an Altman Z-Score of 5.95 and a Piotroski F-Score of 6.
Altman Z-Score | 5.95 |
Piotroski F-Score | 6 |